Milestone Scientific Inc.
MLSS · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -12.2% | 11.6% | -14.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 74.6% | 69.1% | 55.7% | 61.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -77.9% | -71.7% | -99.5% | -70.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -54.6% | -70.5% | -98.9% | -66.2% |
| EPS Diluted | -0.059 | -0.095 | -0.12 | -0.1 |
| % Growth | 37.9% | 20.7% | -20% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |